Variant Bio is using the enormous power of human genetic diversity to discover a new generation of therapeutics.
Variant Bio is searching the globe for people who are medical or genomic outliers in order to identify the genes and pathways driving these traits, with the goal of uncovering the targets for tomorrow’s drugs and advancing much-needed therapies to market.
- Akhila Kosaraju
- Kaja Wasik
- Stephane Castel
- Variant Bio is thrilled to welcome our new Chief R&D Officer, Dr. Tom Rush @tsrush3, to the team. Tom draws on exte… https://t.co/NCAunnsChR
- Check out the podcast Variant's CSO @kajawasik gave on the power of genetic diversity in drug development, now avai… https://t.co/6M3a7gGpHO
- If you're celebrating Nowruz (Persian New Year) this weekend, you're likely to have some saffron in your meal. Scie… https://t.co/WO1doEWyN1